ARS Pharmaceuticals, Inc. SPRY Net margin

Net margin at other companies

Aquestive Therapeutics, Inc.AQST

-137.1%+80.7pp

Amneal Pharmaceuticals, Inc.AMRX

5%+4.9pp

ViatrisVTRS

-2.8%-1.3pp

AMP

Amphastar PharmaceuticalsAMPH

10.8%-7.9pp

Neuropace, Inc.NPCE

-21.7%-4.5pp

Eton Pharmaceuticals, Inc.ETON

-9.5%-2.7pp

FAQ

What is ARS Pharmaceuticals, Inc.'s net margin?

ARS Pharmaceuticals, Inc. (SPRY) reported net margin of -200% in Q1 2026.

How has ARS Pharmaceuticals, Inc.'s net margin changed year-over-year?

ARS Pharmaceuticals, Inc.'s net margin decreased by 1141.2% year-over-year, from -16.1% to -200%.

What is the long-term trend for ARS Pharmaceuticals, Inc.'s net margin?

Over 3 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s net margin has grown at a -57.4% compound annual growth rate (CAGR), from -2,635.4% to -203.3%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.